TTR Amyloidosis: An Underrecognized Disease - Summary - MDSpire
Clinical Guidelines

TTR Amyloidosis: An Underrecognized Disease

Dr. Tushak describes pathology of amyloidosis and screening algorithm for patient identification and management.

  • April 7, 2026

Share

Dr. Tushak outlines the pathology of amyloidosis, a rare disease characterized by the abnormal deposition of amyloid proteins in tissues and organs. The discussion includes criteria for patient identification through a structured screening algorithm, facilitating early diagnosis and effective management strategies that may vary based on the type of amyloidosis present. This comprehensive overview emphasizes the importance of timely intervention in improving patient outcomes.

Original Source(s)

TTR Amyloidosis: An Underrecognized Disease

  • April 7, 2026

Related Content

Masters Athletes Present Unique CV Findings

Joint clinical consensus outlines evaluation and management considerations for arrhythmias, coronary atherosclerosis, aortic dilatation, myocardial fibrosis, and related findings in older competitive athletes.

Surgical thoracic duct decompression: The right choice for Fontan-associated protein-losing enteropathy?

A newly published article in JTCVS Techniques presents an innovative cardiothoracic surgical approach focused on addressing a specific technical challenge while supporting efficiency and reproducibility in the operating room.

  • by

  • April 6, 2026

  • 1 min
Surgical Systemic Vein Turndown For Thoracic Duct Decompression in Fontan Patients With Protein-Losing Enteropathy: Role of Multimodality Imaging

A recent American College of Cardiology expert analysis reviews surgical systemic vein (innominate vein) turndown as a promising treatment for protein?losing enteropathy (PLE) in patients with Fontan circulation.

  • by

  • April 6, 2026

  • 1 min